High CTC levels predicted poor outcome in metastatic breast cancer

Denosumab delayed first skeletal-related side effect

CTCs predict poor outcome from blood stem cell transplantation therapy for metastatic breast cancer

Union for International Cancer Control: successes and the future

Cellular mechanisms of cancer cell dissemination and metastases formation

Chemoradiotherapy for bladder cancer

Computational modelling of signalling pathways

Roundtable discussion on the advances in myeloma and benefit for patients

Genomic sequencing in myeloma

Genomic analysis of myeloma patients

Hypomethylation in myeloma

Roundtable discussion on the recent research advances in multiple myeloma